Children and providers’ perspectives on once-weekly rifapentine and isoniazid TB preventive therapy
BACKGROUND: TB preventive treatment (TPT) prevents the development of TB disease in individuals at risk of progression from infection to disease. However, implementation of TPT for children is poor in most high-burden settings. The long duration and pill burden of the 6-month once-daily isoniazid re...
Saved in:
Main Authors: | A.J. Marthinus, D.T. Wademan, Z. Saule, Y. Hirsch-Moverman, L. Viljoen, J. Winckler, L. van der Laan, M. Palmer, S.L. Barnabas, R. Boyd, A.C. Hesseling, G. Hoddinott |
---|---|
Format: | Article |
Language: | English |
Published: |
International Union Against Tuberculosis and Lung Disease (The Union)
2025-01-01
|
Series: | IJTLD Open |
Subjects: | |
Online Access: | https://www.ingentaconnect.com/contentone/iuatld/ijtldo/2025/00000002/00000001/art00004 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Acceptability of levofloxacin dispersible and non-dispersible tablet formulations in children receiving TB preventive treatment
by: D. T. Wademan, et al.
Published: (2024-02-01) -
Genotyped cluster investigations versus standard contact tracing: comparative impact on latent tuberculosis infection cascade of care in a low-incidence region
by: Michael Asare-Baah, et al.
Published: (2025-01-01) -
Three months of weekly rifapentine plus isoniazid for TB prevention among people with HIV
by: R. Borse, et al.
Published: (2024-09-01) -
Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda
by: A. Musinguzi, et al.
Published: (2024-02-01) -
The paediatric liver transplant experience in Johannesburg, South Africa: A broad overview and update
by: K Kinandu, et al.
Published: (2024-04-01)